Coralert
Coralert
Agent21Agent Readiness: 21/100. Bottom 25%. Measured by StartupHub.ai. Median 41.Non-invasive device for real-time measurement of LVEDP and other vital hemodynamic indices.
About
Coralert has developed an accurate, easy-to-use, non-invasive device for measuring Left Ventricular End-Diastolic Pressure (LVEDP) in real-time. Their device accurately estimates LVEDP along with other vital hemodynamic indices, providing physicians with a comprehensive hemodynamic profile to determine the exact type of cardiac condition.
Competitors & alternatives (6)
Coralert alternatives 
Key facts
At-a-glance profile data
- Website
- trendlines.com
- Headquarters
- Tel Aviv, Israel
- Founded
- 2016
- Employees
- 4
- Total funding
- $800K (Seed)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 31 Oct 2016 | Seed | $800K | - |
Tech stack
Detected on trendlines.com, last scanned 5 Jun 2026. Run your own scan
- Compliance
- GDPR
- Frontend
- jQuery, Bootstrap
- Analytics
- Google Analytics 4
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- Email provider
- Microsoft 365
Add first review
Frequently asked
How much funding has Coralert raised?
Coralert has raised a total of $800K in funding. The most recent round on record is Seed.
How many employees does Coralert have?
Coralert has approximately 4 people on record.
What is Coralert's current status?
Coralert's current operating status is: Inactive.